N. DePolo

VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum.

P. Sheridan, T. Dubensky, D. Jolly, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

The Resistance of Retroviral Vectors Produced from Human Cells to Serum Inactivation In Vivo and In Vitro Is Primate Species Dependent

T. Dubensky, A. Watt, K. Murthy, 1999, Journal of Virology.

Generation of retroviral packaging and producer cell lines for large-scale vector production and clinical application: improved safety and high titer.

S. Chang, P. Sheridan, T. Dubensky, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Evaluation of PCR and ELISA assays for screening clinical trial subjects for replication-competent retrovirus.

D. Martineau, S. Mento, W. Klump, 1997, Human gene therapy.